Bi-Dar (Peter) Wang, PhD
Professor, Pharmaceutical Sciences
Education
- Ph.D. – Microbiology & Biochemistry, National Taiwan University
- M.S. – Microbiology & Biochemistry, National Taiwan University
- B.S. – Biology & Chemistry, National Taiwan University
Bio
Dr. Wang received his Ph.D. degree in Microbiology and Biochemistry from National Taiwan University. He pursued his postdoctoral training at the Institute of Molecular Biology of Academia Sinica and research fellowship training at NICHD/NIH (2002-2006). During his training at NIH, Dr. Wang received a Fellows Award for Research Excellence (FARE) in 2006. After his training at NIH, he was appointed as a senior scientist, then an Assistant Research Professor (2010-2016) in the Department of Pharmacology & Physiology at the George Washington University Medical Center. Dr. Wang joined UMES School of Pharmacy in 2016.
Dr. Wang’s research work focuses on integrative genomics in cancer development/progression and cancer health disparities. He utilized approaches of molecular and cell biology, genomic (array- and sequencing-based), biochemistry, histology, and pharmacology to study the molecular mechanisms underlying prostate cancer disparities. Dr. Wang is also interested in the identification of molecular signatures, microRNA-mRNA pairings, aberrant splicing variations, and epigenetic profiles in aggressive prostate, colon, breast, and liver cancers. His research works have been supported by funding from NCI, DoD, NIGMS, and the American Cancer Society. To see more of Dr. Wang’s research, click on the following link. https://scholar.google.com/citations?user=obdv9EgAAAAJ&hl=en&oi=ao
Areas of Interest and/or Experience
- Cancer genomics and cancer health disparities
- Development of novel biomarkers and drug targets in prostate, colon, liver and breast cancers
- Pharmacological assays in in-vitro cancer cell models and in-vivo xenograft/metastasis models
